Humulin®

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

HUMULIN® (insulin human): Use With COVID-19 Vaccinations

N/A

US_cFAQ_INS768_CONSUMER_USE_WITH_COVID19_VACCINE
cFAQ
cFAQ
US_cFAQ_INS768_CONSUMER_USE_WITH_COVID19_VACCINE
en-US

Use of COVID-19 Vaccines in Patients Receiving Insulin Human

The safety and efficacy of insulin human used in patients who have received a COVID-19 vaccine have not been studied by Eli Lilly and Company. Please talk to your health care provider about whether you should get a COVID-19 vaccine.

For additional questions regarding your treatment with insulin human and a COVID-19 vaccine, contact your health care provider. For current information and updates on a potential COVID-19 vaccine, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.

Date of Last Review: January 25, 2021


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical